|
US2913451A
(en)
|
1957-04-04 |
1959-11-17 |
Mallinckrodt Chemical Works |
Iodophenylamidoalkanesulfonic acid compounds
|
|
US5759515A
(en)
*
|
1989-08-09 |
1998-06-02 |
Rhomed Incorporated |
Polyvalent peptide pharmaceutical applications
|
|
US5700444A
(en)
*
|
1992-02-20 |
1997-12-23 |
Rhomed Incorporated |
Chemotactic peptide pharmaceutical applications
|
|
US6146657A
(en)
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
|
US5305757A
(en)
|
1989-12-22 |
1994-04-26 |
Unger Evan C |
Gas filled liposomes and their use as ultrasonic contrast agents
|
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
|
US5773024A
(en)
|
1989-12-22 |
1998-06-30 |
Imarx Pharmaceutical Corp. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
|
US5469854A
(en)
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
|
US20020032313A1
(en)
|
1991-03-29 |
2002-03-14 |
Genentech, Inc. |
Vascular endothelial cell growth factor antagonists
|
|
OA10149A
(en)
|
1991-03-29 |
1996-12-18 |
Genentech Inc |
Vascular endothelial cell growth factor antagonists
|
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
|
US5861301A
(en)
|
1992-02-20 |
1999-01-19 |
American Cayanamid Company |
Recombinant kinase insert domain containing receptor and gene encoding same
|
|
US5965132A
(en)
|
1992-03-05 |
1999-10-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
|
EP1306095A3
(en)
|
1992-03-05 |
2003-06-25 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
|
US5580563A
(en)
*
|
1992-05-01 |
1996-12-03 |
Tam; James P. |
Multiple antigen peptide system having adjuvant properties, vaccines prepared therefrom and methods of use thereof
|
|
US6824777B1
(en)
|
1992-10-09 |
2004-11-30 |
Licentia Ltd. |
Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
|
|
KR100335584B1
(ko)
|
1992-10-28 |
2002-11-29 |
제넨테크, 인코포레이티드 |
혈관내피세포성장인자에대한길항제
|
|
DK0751992T3
(da)
|
1994-03-08 |
2006-03-06 |
Human Genome Sciences Inc |
Karendotelvækstfaktor 2
|
|
US6245530B1
(en)
|
1995-08-01 |
2001-06-12 |
Ludwig Institute For Cancer Research |
Receptor ligand
|
|
US6130071A
(en)
|
1997-02-05 |
2000-10-10 |
Helsinki University Licensing, Ltd. |
Vascular endothelial growth factor C (VEGF-C) ΔCys156 protein and gene, and uses thereof
|
|
US6221839B1
(en)
|
1994-11-14 |
2001-04-24 |
Helsinki University Licensing Ltd. Oy |
FIt4 ligand and methods of use
|
|
US6645933B1
(en)
|
1995-08-01 |
2003-11-11 |
Helsinki University Licensing Ltd. Oy |
Receptor ligand VEGF-C
|
|
US6403088B1
(en)
|
1995-08-01 |
2002-06-11 |
Helsinki University Licensing, Ltd. |
Antibodies reactive with VEGF-C, a ligand for the Flt4 receptor tyrosine kinase (VEGFR-3)
|
|
US6033645A
(en)
|
1996-06-19 |
2000-03-07 |
Unger; Evan C. |
Methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
|
CA2218541A1
(en)
|
1995-06-07 |
1996-12-19 |
Imarx Pharmaceutical Corp. |
Novel targeted compositions for diagnostic and therapeutic use
|
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
|
US7727761B2
(en)
|
1995-08-01 |
2010-06-01 |
Vegenics Limited |
Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
|
|
US6361946B1
(en)
|
1997-02-05 |
2002-03-26 |
Licentia Ltd |
Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
|
|
PT848755E
(pt)
|
1995-09-08 |
2003-12-31 |
Genentech Inc |
Proteina relacionada com o vegf
|
|
GB9708265D0
(en)
|
1997-04-24 |
1997-06-18 |
Nycomed Imaging As |
Contrast agents
|
|
US6261537B1
(en)
|
1996-10-28 |
2001-07-17 |
Nycomed Imaging As |
Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors
|
|
US6331289B1
(en)
|
1996-10-28 |
2001-12-18 |
Nycomed Imaging As |
Targeted diagnostic/therapeutic agents having more than one different vectors
|
|
BR9712683A
(pt)
|
1996-10-28 |
1999-10-19 |
Nyomed Imaging A S |
Agente de diagnóstico e/ou terapeuticamente ativo alvejável, formulação combinada, processo para preparação e uso do mesmo, formulação combinada, e processos para gerar imagens intensificadas de um corpo animal humano ou não-humano e para investigação in vitro de alvejamento por um agente.
|
|
CA2269985A1
(en)
|
1996-10-28 |
1998-05-07 |
Aslak Godal |
Improvements in or relating to diagnostic/therapeutic agents
|
|
US7125714B2
(en)
|
1997-02-05 |
2006-10-24 |
Licentia Ltd. |
Progenitor cell materials and methods
|
|
US20020010137A1
(en)
|
1997-09-18 |
2002-01-24 |
Genentech, Inc. |
Methods and compositions for inhibiting neoplastic cell growth
|
|
US6245318B1
(en)
|
1997-05-27 |
2001-06-12 |
Mallinckrodt Inc. |
Selectively binding ultrasound contrast agents
|
|
JP4405597B2
(ja)
|
1997-06-18 |
2010-01-27 |
メルク エンド カムパニー インコーポレーテッド |
ヒト受容体型チロシンキナーゼｋｄｒ
|
|
US6777534B1
(en)
|
1997-12-09 |
2004-08-17 |
Children's Medical Center Corporation |
Peptide antagonists of vascular endothelial growth factor
|
|
AU757658B2
(en)
*
|
1998-03-09 |
2003-02-27 |
Zealand Pharma A/S |
Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
|
|
US6524553B2
(en)
|
1998-03-31 |
2003-02-25 |
Bristol-Myers Squibb Pharma Company |
Quinolone vitronectin receptor antagonist pharmaceuticals
|
|
US6548663B1
(en)
|
1998-03-31 |
2003-04-15 |
Bristol-Myers Squibb Pharma Company |
Benzodiazepine vitronectin receptor antagonist pharmaceuticals
|
|
ES2241313T3
(es)
|
1998-03-31 |
2005-10-16 |
Bristol-Myers Squibb Pharma Company |
Compuestos farmaceuticos para la formacion de imagenes de trastornos angiogenicos.
|
|
US6537520B1
(en)
|
1998-03-31 |
2003-03-25 |
Bristol-Myers Squibb Pharma Company |
Pharmaceuticals for the imaging of angiogenic disorders
|
|
US6548048B1
(en)
|
1998-04-28 |
2003-04-15 |
Amersham Health As |
Lipopeptide stabilized microbubbles as diagnostic/therapeutic agents
|
|
US20030236190A1
(en)
|
1998-09-02 |
2003-12-25 |
Renuka Pillutla |
Isulin and IGF-1 receptor agonists and antagonists
|
|
US6875741B2
(en)
|
1998-09-02 |
2005-04-05 |
Renuka Pillutla |
Insulin and IGF-1 receptor agonists and antagonists
|
|
US7173005B2
(en)
|
1998-09-02 |
2007-02-06 |
Antyra Inc. |
Insulin and IGF-1 receptor agonists and antagonists
|
|
DE19941092A1
(de)
|
1999-08-30 |
2001-03-01 |
Philips Corp Intellectual Pty |
Netzwerk mit einer Kennungsreduktion
|
|
WO2001052875A1
(en)
|
2000-01-18 |
2001-07-26 |
Ludwig Institute For Cancer Research |
Vegf-d/vegf-c/vegf peptidomimetic inhibitor
|
|
US7740841B1
(en)
|
2000-01-28 |
2010-06-22 |
Sunnybrook Health Science Center |
Therapeutic method for reducing angiogenesis
|
|
EP1252177A1
(en)
|
2000-02-04 |
2002-10-30 |
Supratek Pharma, Inc. |
Ligand for vascular endothelial growth factor receptor
|
|
US20020102260A1
(en)
|
2000-03-02 |
2002-08-01 |
Marc Achen |
Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissue
|
|
US20010038842A1
(en)
|
2000-03-02 |
2001-11-08 |
Marc Achen |
Methods for treating various cancers expressing vascular endothelial growth factor D, for screening for a neoplastic disease and for maintaining vascularization of tissue
|
|
DK1259248T3
(da)
|
2000-03-02 |
2005-04-11 |
Ludwig Inst Cancer Res |
Fremgangsmåde til behandling af cancere, der udtrykker vaskulær endotelvækstfaktor D
|
|
US20010031485A1
(en)
|
2000-03-22 |
2001-10-18 |
Sibtech, Inc. |
Recombinant proteins containing Shiga-like toxin and vascular endothelial growth factor fragments
|
|
JP2003528632A
(ja)
|
2000-03-31 |
2003-09-30 |
インスティティ・パスツール |
血管内皮成長因子（ｖｅｇｆ）−媒介性脈管形成を阻害するペプチド、該ペプチドをエンコードするポリヌクレオチド及びその使用方法
|
|
WO2001082870A2
(en)
|
2000-05-03 |
2001-11-08 |
Ludwig Institute For Cancer Research |
A method for activating only the vascular endothelial growth factor receptor-3 and uses thereof
|
|
PT1292335E
(pt)
|
2000-06-23 |
2007-08-13 |
Bayer Schering Pharma Ag |
Combinações e composições que interferem na função de receptores vegf/vegf e angiopoietina/ tie e a sua utilização (ii)
|
|
EP1166798A1
(en)
|
2000-06-23 |
2002-01-02 |
Schering Aktiengesellschaft |
Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/ Tie receptor function and their use
|
|
EP1166799A1
(en)
|
2000-06-28 |
2002-01-02 |
Schering Aktiengesellschaft |
Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/Tie receptor function and their use (II)
|
|
EP1311277A4
(en)
|
2000-07-18 |
2004-08-25 |
Joslin Diabetes Center Inc |
METHODS OF FIBROSIS MODULATION
|
|
US20020091082A1
(en)
|
2000-09-13 |
2002-07-11 |
Aiello Lloyd P. |
Methods of modulating symptoms of hypertension
|
|
US20030082103A1
(en)
|
2000-10-11 |
2003-05-01 |
Targesome, Inc. |
Targeted therapeutic lipid constructs having cell surface targets
|
|
US20020091567A1
(en)
*
|
2001-01-09 |
2002-07-11 |
Royston Tymarshall E. |
System and method for electronically redeeming coupons
|
|
US7611711B2
(en)
|
2001-01-17 |
2009-11-03 |
Vegenics Limited |
VEGFR-3 inhibitor materials and methods
|
|
JP2004525916A
(ja)
|
2001-03-08 |
2004-08-26 |
ターゲサム・インコーポレーテッド |
安定化された治療剤および撮像剤
|
|
US20030176674A1
(en)
|
2001-04-13 |
2003-09-18 |
Rosen Craig A. |
Vascular endothelial growth factor 2
|
|
WO2003035839A2
(en)
|
2001-10-24 |
2003-05-01 |
Dgi Biotechnologies, Inc. |
Target specific screening andits use for identifying target binders
|
|
SI2301587T1
(sl)
*
|
2002-03-01 |
2014-11-28 |
Dyax Corp. |
KDR in VEGF/KDR vezavni peptidi in njihova uporaba pri diagnozi
|
|
US7211240B2
(en)
|
2002-03-01 |
2007-05-01 |
Bracco International B.V. |
Multivalent constructs for therapeutic and diagnostic applications
|
|
JP2005519980A
(ja)
*
|
2002-03-01 |
2005-07-07 |
ブラッコ インターナショナル ビー．ヴイ． |
治療および診断用途の多価構成物
|
|
WO2004065621A1
(en)
|
2002-03-01 |
2004-08-05 |
Dyax Corp. |
Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
|
|
EP1501357A4
(en)
|
2002-05-06 |
2009-10-21 |
Genentech Inc |
USE OF VEGF FOR THE TREATMENT OF BONE DEFECTS
|
|
US20040212193A1
(en)
|
2002-10-08 |
2004-10-28 |
Johnstone Ian David |
Connector
|
|
NO20026285D0
(no)
|
2002-12-30 |
2002-12-30 |
Amersham Health As |
Nye peptider
|
|
NO20026286D0
(no)
|
2002-12-30 |
2002-12-30 |
Amersham Health As |
Nye peptider
|
|
US7183256B2
(en)
|
2003-03-21 |
2007-02-27 |
Cleveland Clinic Foundation |
TIMP3 as VEGF inhibitor
|
|
US7601341B2
(en)
|
2003-06-05 |
2009-10-13 |
Research Development Foundation |
Vascular endothelial growth factor fusion constructs used to inhibit osteoclastogenesis
|
|
WO2005011722A2
(en)
|
2003-06-12 |
2005-02-10 |
Ludwig Institute For Cancer Research |
Use of vegf-c or vegf-d in reconstructive surgery
|
|
US20050032697A1
(en)
|
2003-06-12 |
2005-02-10 |
Kari Alitalo |
Heparin binding VEGFR-3 ligands
|
|
JP2005110508A
(ja)
|
2003-10-02 |
2005-04-28 |
Nec Soft Ltd |
血管内皮増殖因子受容体２型に対する特異的結合性を有するヘビ毒由来血管内皮増殖因子様タンパク質と用途
|
|
EP1715897B2
(en)
|
2004-01-20 |
2013-10-30 |
Sunnybrook and Women's College Health Sciences Centre |
High frequency ultrasound imaging using contrast agents
|
|
WO2005072417A2
(en)
|
2004-01-27 |
2005-08-11 |
The Ohio State University Research Foundation |
Vascular endothelial growth factors and methods of their use
|
|
EP1786451A4
(en)
|
2004-08-06 |
2009-07-22 |
Sopherion Therapeutics Inc |
ANTIANGIOGENIC PEPTIDES AND METHOD FOR THEIR USE
|